20 results
424B5
NEXI
Neximmune Inc
5 Feb 24
Prospectus supplement for primary offering
4:34pm
candidates into, and successfully complete, clinical trials;
our ability to recruit and enroll suitable patients in our clinical trials;
the timing … ability to recruit and enroll suitable patients in our clinical trials;
the timing or likelihood of the accomplishment of various scientific, clinical
424B5
vupvwl9zknj
17 Jun 22
Prospectus supplement for primary offering
4:49pm
S-3
959h6 wf8b2iveej
9 Mar 22
Shelf registration
5:14pm
10-Q
2q5xpqj
17 May 21
Quarterly report
4:14pm
10-K
ivf15pvn1q 68d
31 Mar 21
Annual report
4:02pm
424B4
ijyt 28bcese
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
bq7j3bauziaf 8oa6s
8 Feb 21
IPO registration (amended)
7:29am
S-1
88pn3pp 6mgzlofmy
19 Jan 21
IPO registration
4:38pm
DRS/A
2wbs hoxsnj
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
3eo7eakm89ydnzy o2e
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next